Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05373329 · ClinicalTrials.gov registry record · NA
Testing a Digital Health Intervention App for Depression and Anxiety
A NA study, sponsored by University of Nevada, Las Vegas.
- Completed
- Registry status
- NA
- Development phase
- 4,607
- Enrollment target
NCT05373329: Completed NA study, sponsored by University of Nevada, Las Vegas.
NCT05373329 is a NA study that has completed, run by University of Nevada, Las Vegas. The registered enrollment target is 4,607 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (228% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05373329, a NA study, has completed, sponsored by University of Nevada, Las Vegas.
- COMPLETED
- Registry status
- NA
- Development phase
- 4,607 participants
- Enrollment target
Study Summary
Although mobile applications ("apps") for mental health are popular and widely available, little is known about how well they actually help people with common mental health symptoms of depression, anxiety, and stress. We are partnering with a commercially available app to test how well this app helps people's mental health over 8 weeks. Participants will be randomly assigned (like flipping a coin) to two groups: (a) using the app, (b) no app until after 8 weeks. We will ask participants to complete online surveys about their mood and well-being so we can better understand the effects of these different treatments.
Primary Outcome
Participants self-reported depression symptoms. Scores range from 0 to 27 where higher scores indicate poorer outcomes (more severe depression).
Interventions
- DEVICE Sanvello (app)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,607 participants |
| Start Date | 2021-06-14 |
| Est. Completion | 2022-02-04 |
| Phase | NA |
What the finished NCT05373329 record still lists
NCT05373329 is an interventional study that assigns participants to a tested intervention. Its 4,607 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (228% higher).
The record links to 0 conditions, and to 1 intervention - of which Sanvello (app) is the first listed.
NCT05373329 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05373329 about?
NCT05373329 is a clinical study titled "Testing a Digital Health Intervention App for Depression and Anxiety". Although mobile applications ("apps") for mental health are popular and widely available, little is known about how well they actually help people with common mental health symptoms of depression, anxiety, and stress. We are partnering with a commercially available app to test how well this app help...
What is the current status of trial NCT05373329?
This trial is currently completed. It is a NA study. The enrollment target is 4,607 participants. The study started on 2021-06-14. Estimated completion is 2022-02-04.
What interventions are being tested in trial NCT05373329?
The interventions under investigation include: Sanvello (app) (DEVICE).
Who is sponsoring clinical trial NCT05373329?
This trial is sponsored by University of Nevada, Las Vegas, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05373329's enrollment target sits among peer trials
4,607 28th of 2000 higher than 1,973 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05768217 · 4,600 participants · NA
Community Resiliency Collective Efficacy Intervention
- NCT06535139 · 4,630 participants · NA
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
- NCT04371900 · 4,700 participants · NA
Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1
- NCT05486572 · 4,700 participants · NA
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI